Ivan Kruljac, MD, PhD

Dr. Kruljac graduated  from the University of Zagreb Medical School with an excellent grade, and received his PhD from the same faculty in 2016 with an epidemiological study of clinical significance of ketosis in patients with type 2 diabetes. He gained extensive clinical experience at the Department of Endocrinology as the head of the tumor board for neuroendocrine tumors, where he dealt with the most complex cases in the field of endocrinological oncology. These patients were referred from other general and university hospitals from Croatia and abroad. His scientific work is especially significant, as he established himself as the most active endocrinologist in Croatia by writing more than 50 papers, some of which are published in most prestigious jounals such as The New England Journal of Medicine. He was the executive editor and co-founder of the scientific journal Endocrine Oncology and Metabolism, which was included in the ICMJE and COPE, as well as in the international bibliographic databases DOAJ, EMBASE and SCOPUS during his tenure. Since 2019, he has been the secretary of the Croatian Endocrinological Society and the Croatian representative in the European Endocrinological Society. He is a research associate at the University of Zagreb Medical School. He is a co-founder and director of the Solmed Clinic, where he is also the head of the Center of Endocrinology. Currently, he is a principal investigator in three cinical trials, and subinvestigator in seven. He is also the head of the scientific unit of the Solmed Group in charge of biostatistics and medical writing.